Comments
Loading...
Monte Rosa Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GLUE | Benzinga
Monte Rosa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-0.360
Quarterly Revenue Estimate
$7.37M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$159.49M
Analyze the earnings history of Monte Rosa Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics | -$0.43 | -$0.36 | — | — | $4.70M | $7.37M | — | — | 08/07/2025 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.53 | -$0.32 | $0.57 | 278.12% | $1.06M | $13.57M | $84.93M | 525.86% | 05/08/2025 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.58 | -$0.37 | $0.23 | 162.16% | $0.00 | $12.79M | $60.65M | 374.18% | 03/20/2025 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.70 | -$0.49 | -$0.29 | 40.82% | $0.00 | $2.62M | $9.22M | 251.76% | 11/07/2024 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.71 | -$0.54 | -$0.43 | 20.37% | $0.00 | $1.35M | $4.70M | 247.78% | 08/08/2024 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.65 | -$0.57 | -$0.53 | 7.02% | $0.00 | $1.40M | $1.06M | -24.00% | 05/09/2024 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.63 | -$0.33 | -$0.58 | -75.76% | $0.00 | $15.15M | $0.00 | -100.00% | 03/14/2024 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.58 | -$0.72 | -$0.70 | 2.78% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.57 | -$0.70 | -$0.71 | -1.43% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.51 | -$0.68 | -$0.65 | 4.41% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.11 | — | -$0.63 | — | $0.00 | — | $0.00 | — | 03/16/2023 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$0.43 | — | -$0.58 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$3.63 | — | -$0.57 | — | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$7.18 | — | -$0.51 | — | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| GLUE | Monte Rosa Therapeutics | — | — | -$0.11 | — | $0.00 | — | $0.00 | — | 03/29/2022 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$4.29 | — | -$0.43 | — | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| GLUE | Monte Rosa Therapeutics | -$3.64 | — | -$3.63 | — | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
Monte Rosa Therapeutics (GLUE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $0.57 | $-0.32 | 278.1 % |
| Q4 | 2025-03-20 | $0.23 | $-0.37 | 162.2 % |
| Q3 | 2024-11-07 | $-0.29 | $-0.49 | 40.8 % |
| Q2 | 2024-08-08 | $-0.43 | $-0.54 | 20.4 % |
Monte Rosa Therapeutics (GLUE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $84.93M | $13.57M | 525.9 % |
| Q4 | 2025-03-20 | $60.65M | $12.79M | 374.2 % |
| Q3 | 2024-11-07 | $9.22M | $2.62M | 251.8 % |
| Q2 | 2024-08-08 | $4.70M | $1.35M | 247.8 % |
FAQ
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics (GLUE) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Monte Rosa Therapeutics (NASDAQ:GLUE)?
The Actual EPS was $0.57, which beat the estimate of $-0.32.
What were Monte Rosa Therapeutics’s (NASDAQ:GLUE) revenues?
The Actual Revenue was $84.9M, which beat the estimate of $13.6M.
Browse earnings estimates, EPS, and revenue on all stocks.
